Actinium Pharmaceuticals, Inc. (ATNM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 90K | 0 | 0 | 0 | 0 | 0 | 0 | 81K | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | -100% | - | - | - | - | -100% | -100% |
| Cost of Goods Sold | 220K | -615K | 0 | 0 | 0 | 204K | 202K | 189K | 216K | 199K | 200K | 209K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 245.68% | - | - |
| Gross Profit | -220K | 615K | 90K | 0 | 0 | -204K | -202K | -189K | -216K | -118K | -200K | -209K |
| Gross Margin % | - | - | 100% | - | - | - | - | - | - | -145.68% | - | - |
| Gross Profit Growth % | - | 401.47% | 144.55% | 100% | 100% | -72.88% | -1% | 9.57% | - | 26.71% | -13.64% | -54.81% |
| Operating Expenses | 5.68M | 7.03M | 5.78M | 7.5M | 16.64M | 7.3M | 12.4M | 12.23M | 9.38M | 10.22M | 14.15M | 15.43M |
| OpEx % of Revenue | - | - | 6424.44% | - | - | - | - | - | - | 12623.46% | - | - |
| Selling, General & Admin | 1.7M | 2.12M | 1.53M | 2.62M | 8.94M | 2.69M | 2.83M | 3.59M | 2.96M | 2.31M | 2.73M | 4.56M |
| SG&A % of Revenue | - | - | 1704.44% | - | - | - | - | - | - | 2846.91% | - | - |
| Research & Development | 4.2M | 4.91M | 4.25M | 4.88M | 7.7M | 4.61M | 9.57M | 8.64M | 6.42M | 7.92M | 11.42M | 10.87M |
| R&D % of Revenue | - | - | 4720% | - | - | - | - | - | - | 9776.54% | - | - |
| Other Operating Expenses | -220K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.9M | -6.41M | -5.69M | -7.5M | -16.64M | -7.5M | -12.6M | -12.42M | -9.6M | -10.34M | -14.35M | -15.64M |
| Operating Margin % | - | - | -6324.44% | - | - | - | - | - | - | -12769.14% | - | - |
| Operating Income Growth % | 64.52% | 14.54% | 54.83% | 39.58% | -73.37% | 27.44% | 12.19% | 20.61% | 17.15% | 8.4% | -46.45% | -99.26% |
| EBITDA | -5.68M | -6.21M | -5.49M | -7.3M | -16.43M | -7.3M | -12.4M | -12.23M | -9.38M | -10.14M | -14.15M | -15.43M |
| EBITDA Margin % | - | - | -6095.56% | - | - | - | - | - | - | -12523.46% | - | - |
| EBITDA Growth % | 65.42% | 14.97% | 55.75% | 40.31% | -75.17% | 28.03% | 12.38% | 20.76% | 17.72% | 8.86% | -47.74% | -101.21% |
| D&A (Non-Cash Add-back) | 220K | 206K | 206K | 204K | 205K | 204K | 202K | 189K | 216K | 199K | 200K | 209K |
| EBIT | -5.9M | -6.41M | -5.69M | -7.5M | -16.64M | -6.65M | -11.57M | -11.35M | -9.6M | -10.34M | -13.28M | -15.18M |
| Net Interest Income | 381K | -1.89M | 561K | 625K | 700K | 853K | 1.03M | 1.06M | 927K | 1.02M | 1.07M | 461K |
| Interest Income | 381K | -1.89M | 561K | 625K | 700K | 853K | 1.03M | 1.06M | 927K | 1.02M | 1.07M | 461K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 381K | 474K | 561K | 625K | 700K | 853K | 1.03M | 1.06M | 927K | 1.02M | 1.07M | 461K |
| Pretax Income | -5.52M | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M |
| Pretax Margin % | - | - | -5701.11% | - | - | - | - | - | - | -11511.11% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5.52M | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M |
| Net Margin % | - | - | -5701.11% | - | - | - | - | - | - | -11511.11% | - | - |
| Net Income Growth % | 65.35% | 10.7% | 55.64% | 39.42% | -83.83% | 28.66% | 12.87% | 25.22% | 21.45% | 12.43% | -40.13% | -95.46% |
| Net Income (Continuing) | -5.52M | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.18 | -0.19 | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 | -0.58 |
| EPS Growth % | 64.71% | 9.52% | 56.76% | 42.11% | -64.52% | 38.24% | 24.49% | 34.48% | 27.91% | 12.82% | -36.11% | -75.76% |
| EPS (Basic) | -0.18 | -0.19 | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 | -0.58 |
| Diluted Shares Outstanding | 31.24M | 31.2M | 31.2M | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M |
| Basic Shares Outstanding | 31.24M | 31.2M | 31.2M | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |